1.Screening of the Presence of Hepatitis B and C Virus Infections in Terminally Failing Human Hearts.
Seong Choon CHOE ; Hyo Soo KIM ; Byung Hee OH
Korean Circulation Journal 2001;31(1):83-93
In order to evaluate the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in terminally failing hearts, we screened the explanted hearts of transplantation recipients for the presence of HBV DNA and HCV RNA. DNA and RNA extractions were taken from explanted failing hearts (N=7) and normal hearts (N=). Polymerase chain reaction (PCR) and in situ PCR of HBV or reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR of HCV were performed. The positivity of HBV in failing hearts was 63% (17/27) and it was 50% (3/6) in normal hearts in PCR. There was no significant difference in the positivity of HBV DNA between failing and normal hearts. The positivity of HCV in failing hearts was 18.5% (5/27) and it was 16.7% (1/6) in normal hearts in nested RT-PCR. There was no significant difference in the positivity of HCV RNA between failing and normal hearts. HCV was very rarely observed in explanted terminally failing hearts and HBV was frequently found in both explanted failing hearts and normal hearts. We concluded that these viruses have little direct causal relationship with the development of heart failure.
DNA
;
Heart Failure
;
Heart*
;
Hepacivirus
;
Hepatitis B virus
;
Hepatitis B*
;
Hepatitis*
;
Humans*
;
Mass Screening*
;
Polymerase Chain Reaction
;
Prevalence
;
RNA
2.Treatment of Hypercholesterolemia in Elderly Patients; From the Viewpoint of Statins.
Seong Choon CHOE ; Sora LEE ; Chul Joon KIM
Journal of the Korean Geriatrics Society 2002;6(4):253-260
No abstract available.
Aged*
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
;
Hypercholesterolemia*
3.Clinical development and trial operations in COVID-19 era
Translational and Clinical Pharmacology 2021;29(4):181-185
no abstract available.
4.Use of Oral Antibiotics in Elderly Gastrointestinal Patients.
Seong Choon CHOE ; Dong Ho LEE
Journal of the Korean Geriatrics Society 2012;16(3):108-113
Oral antibiotics are usually prescribed for geriatric patients for the treatment of infectious diarrhea and management of hepatic encephalopathy. But oral antibiotics have systemic adverse events, so many doctors face the issue of choosing the right antibiotics. Rifaximin, an intestinal topical antibiotic that exhibits a wide antimicrobial activity against both aerobic and anaerobic bacteria, has various indications, such as acute bacterial diarrhea caused by Gram positive and negative bacteria, traveler's diarrhea, small intestine bacterial overgrowth, prevention of infection after gastrointestinal surgery, and the management of hepatic encephalopathy with hyperammoniemia. But there are few clinical trial data on the geriatric population. Hence we reviewed the clinical study data that included geriatric patients in their clinical trials. Based on our literature searches, only one clinical trial on acute bacterial diarrhea was performed only for geriatric patients. Other clinical trials for various indications usually recruited elderly patients, but the number of elderly patients was limited. However, generally speaking, rifaximin showed good efficacy and safety profile in acute bacterial diarrhea caused by Gram positive and negative bacteria, traveler's diarrhea, small intestine bacterial overgrowth, prevention of infection after gastrointestinal surgery, and the management of hepatic encephalopathy with hyperammoniemia; and there were no differences in efficacy and safety, compared to the nongeriatric population. We concluded that rifaximin is a good therapeutic option for various gastrointestinal indications, and shows good efficacy and an excellent safety profile, compared to other oral agents. For more evidence on the geriatric population, we propose clinical trials on elderly patients for each indication.
Aged
;
Anti-Bacterial Agents
;
Bacteria
;
Bacteria, Anaerobic
;
Diarrhea
;
Hepatic Encephalopathy
;
Humans
;
Intestine, Small
;
Rifamycins
5.Antiatherogenic Effect of Naringin Independent of Lipid-Lowering Action in Hypercholesterolemic Rabbits.
Seong Choon CHOE ; Hyo Soo KIM ; Tae Sook JEONG ; Song Hae BOK ; Young Bae PARK
Korean Circulation Journal 1998;28(11):1873-1881
BACKGROUND: Naringin, one of the flavonoids in citrus fruit peels, is known to have antioxidant and hepatotonic effects in animal studies. We evaluated the effect of naringin on 1) blood lipid profiles, 2) regression of fatty streak of aorta, and 3) liver toxicity in diet-induced hypercholesterolemic rabbits. METHODS: New Zealand White Rabbits (2.0 - 2.5 Kg) were divided to three groups; group without treatment, group treated with 100 mg/kg/d or 500 mg/kg/d naringin, and group treated with 1 mg/kg/d or 20 mg/kg/d lovastatin. They were fed on 0.25% or 1.0% cholesterol-containing diet for 8 weeks and then sacrificed. Blood samples were collected for measurement of total cholesterol, HDL-cholesterol, triglyceride, serum GOT and GPT. Aortas and livers were harvested for evaluation of fatty streak and pathologic examination. RESULTS: 1)Feeding of 1% cholesterol diet for eight weeks significantly increased the cholesterol level upto 20 folds. Neither lovastatin nor naringin did lower these marked hypercholesterolemia. But both naringin (500 mg/kg/d) and lovastatin (1 mg/kg/d) significantly reduced the area of fatty streak by 75% and 58%, respectively. Naringin was more effective in inhibition of fat infiltration into liver than lovastatin which showed hepatotoxicity as increase of serum GPT level (p=0.01). 2)Feeding of 0.25% cholesterol diet for eight weeks significantly increased the cholesterol level upto 17 folds. Total cholesterol and triglyceride levels tended to decrease by treatment with naringin (500 mg/kg/d) and lovastatin (20 mg/kg/d), but this decreases were not statistically significant. However, areas of fatty streak significantly decreased by treatment with naringin and lovastatin by 64 and 82%, respectively (p<0.05). Microscopic analysis revealed that foam cell infiltration into intima was significantly reduced by naringin and lovastatin. In contrast to lovastatin, naringin significantly reduced the level of serum GPT (p<0.05). CONCLUSION: Like lovastatin, naringin has strong antiatherogenic action which may not be associated with its very mild lipid lowering action. In contrast to lovastatin, naringin does have hepatoprotective effect.
Animals
;
Aorta
;
Cholesterol
;
Citrus
;
Diet
;
Flavonoids
;
Foam Cells
;
Hypercholesterolemia
;
Liver
;
Lovastatin
;
Rabbits*
;
Triglycerides
6.A Case of Dilated Cardiomyopathy Associated with Autosomal Dominant Polycystic Kidney Disease.
Seong Choon CHOE ; Eun Seok JEON ; Seung Duk HWANG
Journal of the Korean Society of Echocardiography 2001;9(2):152-156
Autosomal dominant polycystic kidney disease is a systemic disorder with cystic manifestations in the kidneys, liver, pancreas, seminal vesicles, and meninges; its noncystic manifestations affect mostly the vascular, cardiac, and connective tissues. Cardiovascular abnormalities, including mitral and aortic valvular prolapse and regurgitation and annuloaortic ectasia, have been considered important extrarenal manifestations of autosomal dominant polycystic kidney disease. But there were no reports with dilated cardiomyopathy in patients with polycystic kidney disease yet. We have experienced a case of dilated cardiomyopathy that is associated by autosomal dominant polycystic kidney disease in 40 year old male patient. Abdominal ultrasonography revealed variable sizes of multiple cysts in both kidneys and echocardiography showed the marked dilatation of left ventricle and severely depressed left ventricular systolic function (ejection fraction=19%). He was treated with diuretics intravenously and orally. Then dyspnea and abdominal distension was improved. This is the first case of dilated cardiomyopathy with autosomal dominant polycystic disease in Korea.
Adult
;
Cardiomyopathy, Dilated*
;
Cardiovascular Abnormalities
;
Connective Tissue
;
Dilatation
;
Dilatation, Pathologic
;
Diuretics
;
Dyspnea
;
Echocardiography
;
Heart Ventricles
;
Humans
;
Kidney
;
Korea
;
Liver
;
Male
;
Meninges
;
Pancreas
;
Polycystic Kidney Diseases
;
Polycystic Kidney, Autosomal Dominant*
;
Prolapse
;
Seminal Vesicles
;
Ultrasonography
7.Screening of the Presence of Enterovirus and Cytomegalovirus Infections in Terminally Failing Human Hearts.
Seong Choon CHOE ; Seok Yeon KIM ; Suk Keun HONG ; Hyo Soo KIM ; Byung Hee OH
Korean Circulation Journal 1998;28(9):1527-1537
BACKGROUND: In order to evaluate the prevalence of enterovirus and cytomegalovirus infections to terminally failing hearts, the presence of enteroviral RNA and cytomegaloviral DNA was screened in the explanted hearts of transplantation recipients. METHODS: RNA and DNA extractions were performed from explanted failing hearts (N=22) and normal hearts (N=5). Reverse transcription-polymerase chain reaction (RT-PCR) of enterovirus and polymerase chain reaction (PCR) of cytomegalovirus were performed. In situ RT-PCR and in situ PCR were performed with positive nucleic acids of viruses. RESULTS: The positivity of enterovirus in failing hearts was 4.4% (1/22) and 0% (0/5) in normal hearts in nested RT-PCR. There was no significant difference in positivity of enteroviral RNA between failing and normal hearts. Nuclei of myocardium was stained in dark-violet color with in situ RT-PCR. The positivity of cytomegalovirus in failing hearts was 45% (10/22) and 40% (2/5) in nested PCR. There was no significant difference in positivity of cytomegaloviral DNA between failing and normal hearts. Nuclei of myocardium was stained in dark-violet color with in situ PCR. Positive chambers of cytomegalovirus were in decreasing tendency according to increasing patient's age. CONCLUSION: Enterovirus was very rarely observed in explanted terminally failing hearts and cytomegalovirus was frequently found both in explanted failing hearts and normal. These viruses have little direct causal relationship with the development of heart failure.
Cardiomyopathy, Dilated
;
Cytomegalovirus Infections*
;
Cytomegalovirus*
;
DNA
;
Enterovirus*
;
Heart Failure
;
Heart*
;
Humans*
;
Mass Screening*
;
Myocardium
;
Nucleic Acids
;
Polymerase Chain Reaction
;
Prevalence
;
RNA
8.Thrombolytic Therapy Followed by Myotomy of Gastrocnemius Muscle in Popliteal Artery Entrapment Syndrome.
In Mok JUNG ; In Whan SEONG ; Seong Choon CHOE ; Eun Seok JEON ; Jin Sun BAE
Journal of the Korean Society for Vascular Surgery 2000;16(2):249-254
Popliteal artery entrapment syndrome (PAES) is rare, but increasingly reported in the literature as a cause of lower limb arterial impairment. Management of a patient with PAES depends on the clinical pictures. Currently, myotomy of the medial head of gastrocnemius muscle with interposition grafting or bypass of diseased popliteal artery has been widely used in cases with a demaged or occluded artery. But, other less extensive therapeutic approaches were also performed instead of it. We present a case of type II popliteal entrapment syndrome in an 36-year-old male. Presenting symptom was exercise- induced pain in his right calf since one month ago. Arteriography showed occlusion in short segment of right popliteal artery and intact distal run-off arteries. After overnight urokinase thrombolysis, residual focal stenosis and medial deviation of popliteal artery were observed. CT scan showed abnormal structure between right popliteal artery and popliteal vein, so, diagnosis was established. After myotomy of the medial head of gastrocnemius muscle, the symptom resolved completely. Post-operative duplex scan showed normal blood flow, even in active plantar flexion of the foot. In our case, early diagnosis and combined approach of endovascular thrombolytic therapy followed by surgical release of popliteal artery enabled to avoid direct vascular surgery such as bypass or interposition grafting with resolution of ischemic symptoms. This thrombolytic therapy does not obviate surgery but may permit a less extensive procedure to be performed in PAES.
Adult
;
Angiography
;
Arteries
;
Constriction, Pathologic
;
Diagnosis
;
Early Diagnosis
;
Foot
;
Head
;
Humans
;
Lower Extremity
;
Male
;
Muscle, Skeletal*
;
Popliteal Artery*
;
Popliteal Vein
;
Thrombolytic Therapy*
;
Tomography, X-Ray Computed
;
Transplants
;
Urokinase-Type Plasminogen Activator
9.A Case of Histologically Confirmed Coxsackiviral Myocarditis Supported by a Left Ventricular Assist Device.
Bo Young SUNG ; Byung Kwan LIM ; Yoon Cheol KIM ; Min Su LEE ; Jung Hee KIM ; Hyun Woong YANG ; Seong Choon CHOE ; In Whan SEONG ; Shin Kwang KANG ; Eui Doo WHANG ; Young LEE ; Eun Seok JEON
Korean Circulation Journal 2000;30(10):1275-1280
Enteroviruses are the most common agents of myocarditis and have been implicates in the pathogenesis of dilated cardiopmyopathy. There are still discrepancies in the association of enterovirus and myocardial disease, partially due to lack of data on detection of virus antigen or viral culture in the tissue. For the treatment of fulminant myocarditis, aggressive hemodynamic support is warranted because of its excellent long-term prognosis. This 16 year-old girl was admitted because of anterior chest pain for a day. She had flu-like symptoms such as fever, sore throat and cough at 2 weeks ago. Electrocardiogram showed sinus tachycardia and ST segment elevations in lead II, III, aVF and V1-V4. Troponin T was positive and creatinine phosphokinase was elevated (1323 IU/L) at emergency room. On emergency echocardiogram, inferior wall motion was decreased and the ejection fraction (EF) was 70%. Coronary angiogram showed no thrombus and no significant stenosis in coronary artery, and spasm was not induced with ergonovine. Conventional treatment for congestive heart failure with digoxin (0.25 mg daily) and furosemide (20 mg t.i.d) was started under the impression of myocarditis. On the first hospital day, pulmonary edema and signs of shock were developed. The whole left ventricular(LV) wall motion were markedly decreased and EF was less than 20% on echocardiogram. Despite of intra-aortic balloon pump (IABP) for 4 hours, shock and pulmonary edema was progressed. Mechanical circulatory support was started with left ventricular assist device (LVAD, Bio-pump, Medtronic Bio-Medicus, USA). At the time of operation, central venous pressure was 24cmH20, systolic blood pressure was 75mmHg, left atrium(LA) and LV was dilated and the whole wall of LV showed almost akinesia , and LA appendage was biopsied. After 126 hours of LVAD, LV wall motion was restored and EF was 79% on echocardiogram. LVAD was removed 10 days after operation and she was discharged on 23 days of hospitalization without any heart failure symptoms. Immunohistochemistry of LA showed enteroviral VP1 capsid protein (primary antibody; NoVo Castra Laboratory, UK) over the entire LA wall. Her serum neutralized coxsackievirus B3 (CVB3, H3 variant of Woodruff strain) in neutralization test using horse anti-CVB3 (Nancy strain) antibody (ATCC, V030-501-560) as a positive control. The titer of neutralization Ab in her serum of 21 days increased more than 4 times than that of 2 days.
Adolescent
;
Blood Pressure
;
Capsid Proteins
;
Cardiomyopathies
;
Central Venous Pressure
;
Chest Pain
;
Constriction, Pathologic
;
Coronary Vessels
;
Cough
;
Creatinine
;
Digoxin
;
Electrocardiography
;
Emergencies
;
Emergency Service, Hospital
;
Enterovirus
;
Ergonovine
;
Female
;
Fever
;
Furosemide
;
Heart Failure
;
Heart-Assist Devices*
;
Hemodynamics
;
Horses
;
Hospitalization
;
Humans
;
Immunohistochemistry
;
Myocarditis*
;
Neutralization Tests
;
Pharyngitis
;
Prognosis
;
Pulmonary Edema
;
Shock
;
Spasm
;
Tachycardia, Sinus
;
Thrombosis
;
Troponin T
10.A Case Report of Infective Endocarditis that Caused by Gemella Haemolysans in a Patient with Ventricular Septal Defect.
Yoon Cheol KIM ; Min Su LEE ; Bo Young KIM ; Jung Woo LEE ; Dae Seung LIM ; Jung A KANG ; Jung Hee KIM ; Bo Young SUNG ; Seong Choon CHOE ; In Whan SEONG ; Eun Seok JEON
Korean Circulation Journal 2000;30(12):1574-1577
Infective endocarditis is the infectious disease that produces vegetation on endocardium. Acute bacterial endocarditis is most frequently caused by Staphylococcus aureus, occurs on a normal heart valve, and subacute endocarditis usually caused by Streptococcus viridans occurs on damaged valves. Gemella haemolysans are gram-positive cocci that is placed in the family Streptococcaceae. As opportunistic pathogen, Gemella haemolysans are able to cause severe localized and generalized infections and it is known that this organism very rarely causes infective endocarditis. The paucity of reports concerning Gemella haemolysans is probably related to the difficulties associated with their identification. Several laboratory tests to prevent misinterpretation of this organism are now suggested. We have experienced a case of infective endocarditis that is caused by Gemella haemolysans in 37 year old male patient with ventricular septal defect. Gemella haemolysans were detected by blood culture and he was treated with intravenous vancomycin with gentamicin and ceftriaxone, and also underwent cardiac surgery. This is the first case of Gemella haemolysans endocarditis of ventricular septal defect in Korea.
Adult
;
Ceftriaxone
;
Communicable Diseases
;
Endocarditis*
;
Endocarditis, Bacterial
;
Endocardium
;
Gemella*
;
Gentamicins
;
Gram-Positive Cocci
;
Heart Septal Defects, Ventricular*
;
Heart Valves
;
Humans
;
Korea
;
Male
;
Staphylococcus aureus
;
Streptococcaceae
;
Thoracic Surgery
;
Vancomycin
;
Viridans Streptococci